Bosutinib
targeted anticancer therapy · kinase inhibitor
Nothing to addWhat this medicine is for
Bosutinib belongs to the "targeted anticancer therapy (kinase inhibitor)" category. This targeted therapy attacks a specific mechanism of tumor cells; it requires a specialized hospital prescription.
Specifically, for Bosutinib: Treats a cancer by targeting tumor cells. Its prescription and administration fall within a specialized setting, often in hospital.
Under which brands it is found
Bosutinib is part of about 5 presentations listed in France. It is available under various trade names and as generics.
- Bosulif
- Bosutinib Biogaran
- Bosutinib Eg
- Bosutinib Teva
- Bosutinib Zentiva
Generics and the original brand are equivalent for the active substance; only the appearance, the name or the excipients may differ.
Do you need a supplement? No.
We put forward no supplement for Bosutinib: that would be forcing a need that does not exist. The great majority of medicines call for no particular supplementation, and acknowledging this is part of the way we work. We design a supplement only where the data support it, across five specific classes.
Talk about it in the community
A space to share among people who are affected: the early days, the habits built up over the years, what each person has found to live better with it. Shared experiences, nothing medical.
Related molecules
To explore in the « Other areas » family and its neighbours.